<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Balamurugan K</submitter><funding>CCR NIH HHS</funding><funding>Intramural NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>4106-17</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3018791</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(24)</volume><pubmed_abstract>Inflammation and hypoxia are known to promote the metastatic progression of tumours. The CCAAT/enhancer-binding protein-δ (C/EBPδ, CEBPD) is an inflammatory response gene and candidate tumour suppressor, but its physiological role in tumourigenesis in vivo is unknown. Here, we demonstrate a tumour suppressor function of C/EBPδ using transgenic mice overexpressing the Neu/Her2/ERBB2 proto-oncogene in the mammary gland. Unexpectedly, this study also revealed that C/EBPδ is necessary for efficient tumour metastasis. We show that C/EBPδ is induced by hypoxia in tumours in vivo and in breast tumour cells in vitro, and that C/EBPδ-deficient cells exhibit reduced glycolytic metabolism and cell viability under hypoxia. C/EBPδ supports CXCR4 expression. On the other hand, C/EBPδ directly inhibits e</pubmed_abstract><journal>The EMBO journal</journal><pubmed_title>The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.</pubmed_title><pmcid>PMC3018791</pmcid><funding_grant_id>HHSN261200800001E</funding_grant_id><funding_grant_id>HHSN261200800001C</funding_grant_id><pubmed_authors>Sterneck E</pubmed_authors><pubmed_authors>Wang JM</pubmed_authors><pubmed_authors>Leighty R</pubmed_authors><pubmed_authors>Sharan S</pubmed_authors><pubmed_authors>Tsai HH</pubmed_authors><pubmed_authors>Balamurugan K</pubmed_authors><pubmed_authors>Anver M</pubmed_authors></additional><is_claimable>false</is_claimable><name>The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.</name><description>Inflammation and hypoxia are known to promote the metastatic progression of tumours. The CCAAT/enhancer-binding protein-δ (C/EBPδ, CEBPD) is an inflammatory response gene and candidate tumour suppressor, but its physiological role in tumourigenesis in vivo is unknown. Here, we demonstrate a tumour suppressor function of C/EBPδ using transgenic mice overexpressing the Neu/Her2/ERBB2 proto-oncogene in the mammary gland. Unexpectedly, this study also revealed that C/EBPδ is necessary for efficient tumour metastasis. We show that C/EBPδ is induced by hypoxia in tumours in vivo and in breast tumour cells in vitro, and that C/EBPδ-deficient cells exhibit reduced glycolytic metabolism and cell viability under hypoxia. C/EBPδ supports CXCR4 expression. On the other hand, C/EBPδ directly inhibits e</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Dec</publication><modification>2025-04-26T05:09:07.032Z</modification><creation>2019-03-27T00:37:59Z</creation></dates><accession>S-EPMC3018791</accession><cross_references><pubmed>21076392</pubmed><doi>10.1038/emboj.2010.280</doi></cross_references></HashMap>